R&D Analysis

Understanding the realm of Pharmaceuticals to create value based decisions and help clients achieve better outcomes in their R&D endeavors
Request for proposal
Efficiency in R&D is calculated more often than not through the return on investments made on therapeutic candidates, when they reach their commercialization stage and are able to earn revenue for the company who has developed it.

Our Perspective

The most basic way to understand the candidate’s journey through pre-clinical and clinical development is by assessing the same parameters of other candidates already in the space. To help pharmaceutical companies assess the current scenario of a particular indication, or a particular Mechanism of Action, or a particular Active Pharmaceutical Ingredient, or a particular Drug candidate, etc. DelveInsight’s insight-packed reports provide clarity on uncertainties and challenge blind spots to provide timely intelligence to the company.
Our R&D Analysis service provides:

Insights

R&D Analysis study

R&D Analysis

A mid-Pharma client based in India involved DelveInsight to assist in gathering and analyzing congress abstracts and literature review from various congresses for Parkinson’s disease. [...]

Due Diligence study

Due Diligence

A medium pharmaceutical client with capabilities in novel formulations was involved in a deal with a manufacturing company for commercial-scale manufacturing of the client’s therapies. [...]

Assest prioritization study

Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

Out-licensing opportunity study

Out-Licensing Opportunity

A Small Pharmaceutical Client Based At Sweden, Europe With Capabilities Around A Neonatal Mesenchymal Cells Involved DelveInsight [...]

Request For Proposal

*I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.